chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8 days post vaccine started having symptoms at upper left arm.No problems with injection site intially other than mild soreness. Symptoms of  swelling, itching, redness, soreness upper right arm began on day 8 post vaccine that worsened over 3 days and then began to subside.  Symptoms cleared up within in 7 days of onset. Visited Immediate Care; HCP stated it appeared to be mild cellulitis. Rx for antibiotic was prescribed but I never took the antibiotic and symptoms cleared on their own.
Guillian Barre; This spontaneous case was received on 06-Oct-2020 from other non-health professional via Novartis (reference number: NUS2020US120173) and concerned patient of an unknown age and gender.  The patient's medical history and concomitant medications were not reported  On an unknown date, the patient was vaccinated with Influenza virus vaccine polyvalent (no generic name; dose, anatomical location, route of administration and indication: not reported). The batch number was not reported.   On an unknown date, an unknown amount of time after vaccination with Influenza virus vaccine polyvalent, the patient developed Guillian Barre.   The outcome of the event was not reported.  The reporter assessed the event to be related to Influenza virus vaccine polyvalent, as it was reported that it was linked to a flu vaccine.  The event of 'Guillian Barre' was considered to be medically significant by a Physician within Seqirus' Pharmacovigilance and Risk Management Department.  This case is linked to 202004618 (the same reporter).  Company comment: A patient of an unknown age developed Guillain Barre syndrome an unknown amount of time after vaccination with Influenza virus vaccine polyvalent. Chronology needs more clarification. The patient's medical history and concomitant medications were not reported. With information available, causal role of the suspect vaccine is assessed as possibly related since GBS is known to be associated with vaccine administration and no alternative aetiology was provided.; Reporter's Comments: It was linked to a flu vaccine.; Sender's Comments: A patient of an unknown age developed Guillain Barre syndrome an unknown amount of time after vaccination with Influenza virus vaccine polyvalent. Chronology needs more clarification. The patient's medical history and concomitant medications were not reported. With information available, causal role of the suspect vaccine is assessed as possibly related since GBS is known to be associated with vaccine administration and no alternative aetiology was provided..
numbness and tingling in hands and feet. My Doctor said he didn't know if it was from the shot . but it happen the same day of the shot.  it lasted 3 full days . and now off and on again.
It was reported that a 21 year old female patient received rabies vaccination on 08-Jun-2000. Reportedly on 9-Jun, the patient developed a local reaction of swelling, redness and pain at the injection site.  From correspondence received on 2-Aug-2000, it was reported that the patient also experienced fatigue, neck pain and arm pain. Reportedly, the patient recovered from the experience. Additional patient, responsible physician, vaccine administrator information was also provided.  From additional correspondence received on 25-Oct-2000, it was reported "Reviewed, no additional information at this time-JH 20-Oct-2000". No further information is expected. This case is closed.
Mom reports "non-stop crying" x 3 days beginning night that vaccine given. Also had diarrhea. Was intermittently fussy before immuniz. also.
Patient admitted to hospital with c/o increasing SOB, increase in LE edema, weight gain, cough; CHF exacerbation; acute heart failure; positive for COVID; A Fib; AKI and worsening renal failure; CHF exacerbation worsened; increase for O2 therapy; multiorgan failure; transferred to ICU; worsening hypoxia, bradycardia, asystole; ACLS protocols with chest compressions performed; family decided to stop compressions and patient died at the hospital.
Approximately 3 to 4 days after the flu shot was administered, the patient noticed a rash on her arm(raised round bumps). The rash started on her arms, then moved to her leg and also on her back. Rash was itchy and sore. The bumps swelled up.
pt recv vax 11AUG95 & 7APR96 pt broke out in an itchy rash all over body;pt presented to MD ofc & was dx w/varicella w/less than 100 lesions dispersed randomly on the body;tx w/colloidal oatmeal  & calamine & DPH;MD advised APAP if a fever;
Chills - Fever (101.4) - Upset Stomach - Body Ache - Head Ache - Tinnitus Symptoms subsided after 12 hours.
Face burning and red, felt weak and shaky, thought I might pass out. Returned to pharmacy where blood pressure and pulse were checked. Blood pressure was OK pulse was a little high for me. Later I experienced aches throughout my entire body, headache and fatigue.
Brachial Neuritis. Arm weakness, inability to rt. arm use without pain. Unable to lift arm. Pain at the base of the skull extending down the neck to the rt arm, down to the pinky finger. Brachial Neuritis now comes and goes without warning, causing severe pain and loss of use of rt. arm.
Breakthrough case admission after 4 vaccines Moderna 1/28/21 Lot# 028L20A;  Moderna 2/25/21 Lot# 004M20A;  Moderna 11/10/21 Lot# 033F21A;  Moderna 4/21/22 Lot# 048L21A
Per Dr.: Patient: Patient had multiple diffuse areas of infarcts of brain and brainstem  of unknown etiology. Covid antibiody profile done:SARS CoV-2Ab, Nucleocapsid- negative; SARS CoV2 Semi-Quant Total: See Dilution; SARS CoV2 Spike Ab Dilution: 11806 (with reference range being negative <0.8).
he reports noticing a (L) supraclavicular nodule about 1-2 days ago
I suffered Vertigo until thru mid October. I continue to feel off balance and have memory fog/lost.  I have under gone physical Therapy, CT scan and MRI scans
Granuloma annulare; Circular raised lesions on hands, feet and chest. Most c/w GA. Bactrim and Prednisone rx by Dermatology. Eucrisa.
Patient tested positive for COVID on 9/20 and was admitted to outside facility on 9/20.  She was treated with remdesivir and has completed 5 of 5 days of treatment.  She is on day 5 of 10 of dexamethasone. Pertinent labs from today include WBC 5.7, HB 15.2, PLT 235, Na 137, K 4.1, creatinine 0.6, albumin 3.3, CRP 22.6, D-dimer 589, BNP 1170, ALT 91, AST 55. Most recent x-ray was completed on 09/22 which showed worsening infiltrates favoring infectious pneumonitis and stable cardiomegaly.  TTE was performed on 9/23 which showed LVEF 55%, mild diastolic dysfunction, mild MR, mild AS, and small pericardial effusion.
Severe / constant TINNITUS  (new onset).  Never experienced prior to vaccination for Covid.  Reported to several physicians.  Neurologist ordered MRI of inner auditory canal.  Result was normal.  Severe tinnitus continues to date.  Continuing treatment with ENT  physician.
Pt developed ADEM - neurologic illness like multiple sclerosis. Had flu-like sx shortly after rec'd flu vaccine.
Patient is fully vaccinated. CHIEF COMPLAINT:  Chest pain, shortness of breath, acute COVID-19  infection.45-year-old white female with a known history of both diabetes mellitus and coronary artery disease presented to the emergency department complaining of chest pain and shortness of breath. Positive for cough and congestion and SOB.  She apparently tested positive for COVID-19 infection on Friday, January 7th at an urgent care clinic. She also experiences racing of her heart with activity and tightness of the chest. She had a chest CT angiogram with a PE protocol, which showed no evidence of acute pulmonary emboli.  No acute intrathoracic process was identified. She was treated with aggressive IV hydration because of her lactic acidosis. She is receiving narcotic analgesics for pain control.  Did not qualify for remdesivir and steriods.  Discharged home.
This spontaneous report was received from a registered nurse and refers to an unknown number of patients of unknown age and gender. There was no information about the patients' concomitant therapies, medical histories and drug reactions or allergies provided. On unknown dates, from 01-FEB-2017 to 28-FEB-2017, the patients were vaccinated with improperly stored doses of M-M-R II lot# M029230, expiration date: 08-JUN-2018; lot# M008588, expiration date: 16-FEB-2018; lot# M035935, expiration date: 09-AUG-2018; lot# M037096, expiration date: 23-AUG-2018 (dose and route of administration were not reported). Administered doses of vaccines experienced the temperature excursion between 47 degrees Fahrenheit and 77 degrees Fahrenheit for 2 hours. Data logger was used to capture temperature excursions. There were no previous temperature excursions. No Product Quality Complaint (PQC) was involved. The nurse stated that the reason for temperature excursion was due to the refrigerator needing service. It was also added that there were no other temperature excursions once the service was completed. Reporter also stated that she would call back with the information regarding patients who received improperly stored vaccines. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA007278: US-009507513-1705USA007277: US-009507513-1703USA005900.
Patient presented to the pharmacy today 11/12/2020 complaining of "shooting" pain in left upper arm/shoulder. Patient says that the pain has gotten worse over the last couple of days; patient unable to elaborate on intensity and exact onset of pain. Patient denies any impaired range of movement or joint pain; movement does not alleviate or intensify pain felt. Patient changed story a couple of times while trying to explain intensity of pain. Initially alleged that pain on day of immunization was not as intense as what she is currently feeling. Later story given by patient claims that the pain was always intense and has remained at same intensity. Patient alleges that only drinking alcoholic beverages allev Patient claimed that only by drinking alcoholic beverages she is able to sleep due to the pain she is currently feeling. She states that she has been applying Vicks and massaging the area in order to achieve pain relief.
I have had a persistent headache for the duration of time since my first Covid shoot.  I also experience nausea. I previously has Covid in March.  I also am experiencing tingling of the tongue since the shot.
12/09/21 presents to ED for "evaluation of hypoxia after testing for COVID". PMHx of "diabetes, hypertension"
Patient reports breaking out in a rash stretching from wrist to shoulder, following typical pattern and appearance of an outbreak of shingles. The rash occurred on the opposite arm of the injection site and is painful, itching, and red.
Information has been received from a Certified Medical Assistant referring to a 16 year old female patient. On 01-APR-2015 the patient was vaccinated with (Merck) PROQUAD (lot # K020755, expiration date 30-APR-2016, dose was not reported), subcutaneously (Inappropriate schedule of drug administration). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Day 1: Severe Chills and muscle aches/102 fever.  Day 2 101 fever, muscle aches, nausea, Day 3 100 fever muscle aches, nausea, Day 4 nausea, diarrhea.
Approximately two weeks after my first vaccine I developed small very itchy blisters. Just a few on my chest and  inner  thigh . They blistered , oozed and itched and now on March 10 are healing . I have had the shingles vaccine but this is all I could think it could be .. a small shingles breakout . The person administering my second dose thought I should report it . My husband developed the worse cold sore I have ever seen .. also approximately two weeks after his first dose. It is taking forever to heal . We are thrilled to get the vaccine and these side effects would not give us any reason not to do it . I was just told to report it .
Narrative: 65 y/0 with history of COPD, CHF, morbid obesity, received 1st dose of COVID19 vaccine (Moderna) 02/21/21. Presented to ED on 03/01/21 c/o shortness of breath and not feeling well since receiving the vaccine. Notes indicate he had stopped taking his maintenance Symbicort inhaler (gives him a headache). Workup indicated symptoms likely related to acute exacerbation of COPD; was prescribed prednisone and recommended to f/u with PCP for optimization of COPD. He did not receive the 2nd COVID19 vaccine.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. It was reported that the patient received two doses of ZOSTAVAX, 19400 PFU 0.65 ml, subcutaneous. One dose of ZOSTAVAX was administered on an unspecified date "last week" (unknown date in 2013). The date of vaccination with the other dose was not provided. No adverse effect reported. Additional information has been requested.
Oral shaped erythematous and slightly warm, firm patch on upper lateral leg. No fluctuance vaccine site reaction.
This spontaneous case, initially received from other health professional on 08-Feb-2018 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medications were not reported. On 12-Dec-2017, a bottle of AFLURIA was opened and stored for more than 28 days. On 08-Feb-2018, the patient was administered with AFLURIA QUADRIVALENT (batch number: 00644611A, expiry date: 30-Jun-2018, dose, route of administration and anatomical location: not reported). It was reported that patient didn't experience any adverse events. The reporter assessed the events as non-serious. Follow-up received on 21-Mar-2018: Follow-up for this case is not being sought as response was not received from the reporter.
1st day a lil out of breath if doing chores had to relax.; Heat rash under right boob showed up today; Just feel warm; This is a spontaneous report from a contactable consumer. This 38-year-old female (patient) reported herself that she received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04May2021 11:30 AM at left arm for COVID-19 immunization. Medical history included anxiety and overweight. The patient had no history of COVID-19 and did not have test for COVID-19. Concomitant drugs included alprazolam for anxiety (patient was naturally high anxiety if did not take alprazolam). On 06May2021 17:45 PM, the patient had heat rash under right boob. The patient was a lil out of breath if doing chores had to relax. Just feel warm. No treatment was received for the events. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
felt very weak; basically slept all day; runny nose and wooziness; runny nose and wooziness; pressure in the back of the head; Proceeded to belching and flatulance.; Proceeded to belching and flatulance.; This is a spontaneous report from a contactable consumer or other non HCP (Patient). A 71-year-old non pregnant female patient received bnt162b2 (BNT162B2, formulation; Solution for injection), via an unspecified route of administration on 06Feb2021 at 01:30 (Batch/Lot Number: el9269) as DOSE NUMBER UNKNOWN, SINGLE (at the age of 71-year-old) for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included diabetes 2, sleep apnea, high blood pressure from an unknown date and unknown if ongoing. Prior to vaccination the patient not diagnosed with COVID-19. The patient had no known allergies. The patient's concomitant medications were not reported. It was reported that about 30 minutes after the vaccination on 06Feb2021 at 14.00, the patient had pressure in the back of the head and proceeded to belching and flatulence. This event continued for about 2 days and the patient felt better on Monday evening. On 10Feb2021 Wednesday, the patient felt very weak, basically slept all day, had runny nose and wooziness. The patient was not tested for COVID post vaccination. The patient underwent lab tests and procedures which included blood pressure measurement: high on un unknown date. No treatment was received for the events. The outcome of events pressure in the back of the head, proceeded to belching and flatulance reported recovered on 08Feb2021 and for other events outcome was unknown.  Follow-up attempts completed. No further information expected.
I was very tired. I had to go to the restroom repeatedly. It wasn't diarrhea though. When I contracted COVID-19 in August 2022, my breathing was very labored. I had chest pain and was coughing a lot. I called my doctor and they prescribed me a steroid and Paxlovid. My coughing is still persistent, but its not as bad.
COVID-19; covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 11May2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "type 2 diabetes" (unspecified if ongoing). Concomitant medication(s) included: ZYRTEC [LEVOCABASTINE HYDROCHLORIDE], start date: 01Jun2010. Past drug history included: Levaquin, reaction(s): "Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "COVID-19"; COVID-19 (medically significant), outcome "unknown", described as "covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
My daughter complaint of not seem correct , I ask her to close her eyes and open slow she reply I still can't see she started crying and she reply once again I can't see I see blurry . today is Monday 9/28/2020 6:44 and she still the same she has to get really closed to the computer, papers,phone when I said close to the items I meant like 5 inches away from her nose . PM. she started Saturday around 6:00 PM
Pain on the pads of my feet (still exists after two weeks) Numbness of torso (lasted exactly two weeks) Swelling over hip replacement area (Hip replaced several years ago)
This spontaneous report was received from healthcare worker concerning a male patient of unknown age. The patient's medical history and drug reactions/allergies were not reported. Recently in 2012, the patient was vaccinated with PNEUMOVAX23. Dose and route were not reported. Lot number was H209825 (in validation). No other co-suspects were reported. No concomitant medications were reported. In 2012, the patient experienced severe reactions as urinary retention and lymph node problems. No treatment information was reported. The outcome of urinary retention and lymph node problems was unknown. The relatedness for urinary retention and lymph node problems was unknown for PNEUMOVAX23. This is one of two reports received from the same source. Additional information has been requested.
3-4 hours after injection donor had nausea, dizziness felt feverish w/chills. Also had a rash on his left lower arm for 1 day. s/s were resolved in 2 days. Donor rested and treated at home - he became sick w/flulike symptoms a couple day after these s/s were resolved.
Day after vaccine given, pt had 5 episodes of vomiting. Mom reported she felt cold, clammy and somewhat lethargic.
Started getting hives/rash really bad. I still have rash and it?s been a little over 2 weeks
THIS WAS A SHIPPED LOT WHICH WAS SENT WITH EXPIRATION SOON AFTER RECEIVING
2-2 1/2 inch spot that reds; felt like a black and blue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (2-2 1/2 inch spot that reds) and INJECTION SITE BRUISING (felt like a black and blue) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L2OA) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (2-2 1/2 inch spot that reds) and INJECTION SITE BRUISING (felt like a black and blue). At the time of the report, VACCINATION SITE ERYTHEMA (2-2 1/2 inch spot that reds) and INJECTION SITE BRUISING (felt like a black and blue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications:- Arnica cream   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Updated events outcome as recovered/resolved.
pt recvd vax & 15mins p/vax exp h/a, & nausea;
pain at injection site, 100 degree fever, chills, shaking, migraine, nausea, loss of appetite
Muscle pain in right upper leg, groin, side and front of leg.  Enough pain that I am limping when I stand up and can't walk very far, due to the pain.  It's been going on for 12 - 13 days and is not improving.  I had no leg injury that I could identify as the source of the pain.
runny nose; sore throat; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 44-year-old male patient started to receive BNT162B2 (Solution for injection, lot number and expiry date unknown), intramuscular on 18Dec2020 at single dose in the left deltoid for COVID Prevention. There were no medical history and concomitant medications. The patient called and stated that he took the COVID vaccine first dose, on Monday, and now he is getting the side effects of running nose and sore throat. Stated that the running nose and sore throat starting this morning on 22Dec2020, right as he woke up, and then it went away, and now it just seems to have gotten worse. He wondered if those are common side effects because he couldn't find them on the facts sheet. He stated that he is just trying to gather more information because he knows that it is currently cold and flu season, and it could also just be allergies. Also he wanted to make sure this is a common side effect, because if not, he has family coming to town to visit him for the holiday and he wants to be safe if he is sick. The outcome of the events was not recovered.  The following information on the batch number has been requested.
Received pneumovax injection, waited in waiting area for lab.  As patient was getting blood drawn became dizzy and faint, put head down.  Unable to obtain pulse or blood presure, called 911.  Slowly began to respond drank juice, blood pressure 110/60, pulse 60, alert.  Transported to emergency room.  At time of blood draw, patient complained of severe pain in lower back which she attributed to pneumovax.  After waiting in ER she left before being seen by doctor.  EKG showed some brachycardia.
SEVERE SWELLING, REDNESS, PAIN AND EDEMA INVOLVING L UPPER ARM AS WELL AS PROXIMAL PART OF L FOREARM.
Right arm swelling, pain and redness at injection site. Slight fever, slept for several hours. When I awoke, I noticed edema of both lower legs. This got progressively worse over the following weeks. Without any symptoms of arthritis prior, I now had it in every joint in my body. Each morning I wake it's a new spot that's decided to hurt the worst, that day. It appears that the reconstruction work done on my knees has disappeared or been wiped out. My hands, which never had pain or swelling, are starting to deform and every finger now triggers from the sudden onset of arthritis. I did not notice it at the time of the first injection, but my heart rate began running 100-120 BPM, and my BP from 215/113 to about 180/105.   We have had some luck with LISINOPRIL-HCTZ, FUROSIMIDE, CLINORIL. It appears to be getting the BP down a bit, but still in the range of 170-180/100-110
transported to the hospital by ambulance due to low blood pressure and fast heart rate 48 hours after 1 st dose